[go: up one dir, main page]

FR2761606B1 - Utilisation de derives aminothiolesters dans le domaine pharmaceutique - Google Patents

Utilisation de derives aminothiolesters dans le domaine pharmaceutique

Info

Publication number
FR2761606B1
FR2761606B1 FR9704283A FR9704283A FR2761606B1 FR 2761606 B1 FR2761606 B1 FR 2761606B1 FR 9704283 A FR9704283 A FR 9704283A FR 9704283 A FR9704283 A FR 9704283A FR 2761606 B1 FR2761606 B1 FR 2761606B1
Authority
FR
France
Prior art keywords
aminothiolester
derivatives
pharmaceutical field
pharmaceutical
field
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR9704283A
Other languages
English (en)
Other versions
FR2761606A1 (fr
Inventor
Gerard Quash
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Centre International de Recherches Dermatologiques Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9704283A priority Critical patent/FR2761606B1/fr
Application filed by Centre International de Recherches Dermatologiques Galderma filed Critical Centre International de Recherches Dermatologiques Galderma
Priority to PCT/FR1998/000712 priority patent/WO1998044919A1/fr
Priority to EP98920590A priority patent/EP0920310A1/fr
Priority to US09/202,068 priority patent/US6028114A/en
Priority to AU73398/98A priority patent/AU724253B2/en
Priority to JP54246398A priority patent/JP3190048B2/ja
Priority to CA002257898A priority patent/CA2257898C/fr
Publication of FR2761606A1 publication Critical patent/FR2761606A1/fr
Application granted granted Critical
Publication of FR2761606B1 publication Critical patent/FR2761606B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/265—Esters, e.g. nitroglycerine, selenocyanates of carbonic, thiocarbonic, or thiocarboxylic acids, e.g. thioacetic acid, xanthogenic acid, trithiocarbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9704283A 1997-04-08 1997-04-08 Utilisation de derives aminothiolesters dans le domaine pharmaceutique Expired - Lifetime FR2761606B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR9704283A FR2761606B1 (fr) 1997-04-08 1997-04-08 Utilisation de derives aminothiolesters dans le domaine pharmaceutique
EP98920590A EP0920310A1 (fr) 1997-04-08 1998-04-08 Utilisation de derives aminothiolesters dans le domaine pharmaceutique
US09/202,068 US6028114A (en) 1997-04-08 1998-04-08 Use of aminothiolester derivatives in pharmaceutics
AU73398/98A AU724253B2 (en) 1997-04-08 1998-04-08 Use of aminothiol ester derivatives in the pharmaceutical field
PCT/FR1998/000712 WO1998044919A1 (fr) 1997-04-08 1998-04-08 Utilisation de derives aminothiolesters dans le domaine pharmaceutique
JP54246398A JP3190048B2 (ja) 1997-04-08 1998-04-08 薬剤分野におけるアミノチオールエステル誘導体の使用
CA002257898A CA2257898C (fr) 1997-04-08 1998-04-08 Utilisation de derives aminothiolesters dans le domaine pharmaceutique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9704283A FR2761606B1 (fr) 1997-04-08 1997-04-08 Utilisation de derives aminothiolesters dans le domaine pharmaceutique

Publications (2)

Publication Number Publication Date
FR2761606A1 FR2761606A1 (fr) 1998-10-09
FR2761606B1 true FR2761606B1 (fr) 1999-05-14

Family

ID=9505645

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9704283A Expired - Lifetime FR2761606B1 (fr) 1997-04-08 1997-04-08 Utilisation de derives aminothiolesters dans le domaine pharmaceutique

Country Status (7)

Country Link
US (1) US6028114A (fr)
EP (1) EP0920310A1 (fr)
JP (1) JP3190048B2 (fr)
AU (1) AU724253B2 (fr)
CA (1) CA2257898C (fr)
FR (1) FR2761606B1 (fr)
WO (1) WO1998044919A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994409A (en) 1997-12-09 1999-11-30 U.S. Bioscience, Inc. Methods for treatment of neuro--and nephro--disorders and therapeutic toxicities using aminothiol compounds
US6489312B1 (en) 1999-06-15 2002-12-03 Medimmune Oncology, Inc. Pharmaceutical formulations comprising aminoalkyl phosphorothioates
FR2809727B1 (fr) * 2000-05-31 2002-07-26 Galderma Res & Dev Nouveaux composes aminothiolesters, compositions pharmaceutiques et cosmetiques les contenant et utilisations
US7078402B2 (en) * 2000-05-31 2006-07-18 Centre National De La Recherche Scientifique (Cnrs) Aminothiol ester compounds, pharmaceutical and cosmetics compositions containing same and uses thereof
US7053072B2 (en) * 2001-05-11 2006-05-30 Medimmune Oncology, Inc. Methods for the administration of amifostine and related compounds
US6916892B2 (en) * 2001-12-03 2005-07-12 Fina Technology, Inc. Method for transitioning between Ziegler-Natta and metallocene catalysts in a bulk loop reactor for the production of polypropylene
FR2983492B1 (fr) * 2011-12-06 2015-10-30 Advanced Biodesign Procede ex vivo de purge tumorale d'un echantillon biologique
FR3047734B1 (fr) * 2016-02-17 2019-09-06 Advanced Biodesign Procede de preparation de composes aminothiolester et leurs sels

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550189B1 (fr) * 1983-08-04 1986-03-28 Centre Nat Rech Scient Nouveaux derives acetyleniques possedant une activite d'inhibiteurs d'enzyme, leur preparation et leur application comme medicament
FR2728790B1 (fr) * 1994-12-29 1997-01-24 Cird Galderma Composition modulant l'apoptose comprenant du methonial ou tout facteur influencant le taux intracellulaire de methonial

Also Published As

Publication number Publication date
CA2257898C (fr) 2003-10-21
US6028114A (en) 2000-02-22
AU7339898A (en) 1998-10-30
FR2761606A1 (fr) 1998-10-09
JPH11513048A (ja) 1999-11-09
EP0920310A1 (fr) 1999-06-09
WO1998044919A1 (fr) 1998-10-15
CA2257898A1 (fr) 1998-10-15
AU724253B2 (en) 2000-09-14
JP3190048B2 (ja) 2001-07-16

Similar Documents

Publication Publication Date Title
ID24654A (id) Formulasi farmasi omeprazola
DE122010000011I1 (de) Flüssige gonadotropinhaltige Arzneimittel
FR2740686B1 (fr) Formulation pharmaceutique lyophilisee stable
CU23048A3 (es) Aminoacidos ciclicos y derivados de los mismos, utiles como agentes farmaceuticos
NO954486D0 (no) Farmasöytiske formuleringsgrunnlag
ID23874A (id) Obat
FI953479A0 (fi) 1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
NO980546D0 (no) Farmasöytiske midler
FI971279L (fi) Lääkkeitä
MA26553A1 (fr) Alpha-aryl-n-alkylnitrones et compositions pharmaceutiques contenant ceux-la
PT1006110E (pt) Derivados de acil-piperazinil-pirimidinas sua preparacao e aplicacao como medicamentos
BR9610396A (pt) Formulação farmacêutica
NO20000231D0 (no) Dolastatin-15-derivater
PT869121E (pt) Derivados de propanolamina hipolipidemicos
FR2761606B1 (fr) Utilisation de derives aminothiolesters dans le domaine pharmaceutique
NO994619L (no) Farmasöytiske blandinger
MA26531A1 (fr) Composition pharmaceutique
NO992724D0 (no) Farmas°ytiske blandinger inneholdende N-sulfonyl-indolin-derivater
DK0925273T3 (da) Farmaceutiske præparater indeholdende 4-oxo-butansyrer
NO20003141D0 (no) Farmasøytiske blandinger
DE69800970D1 (de) Pyridinderivate und sie enthaltende pharmazeutische zubereitungen
FI973230L (fi) Uusi farmaseuttinen formulaatio
DE69722623D1 (de) Verabreichungssystem von funktionellen wirkstoffen
EP1000925A4 (fr) Derives de triphenylmethane et leur utilisation
FR2795732B1 (fr) Utilisation du gene krit1 dans le domaine de l'angiogenese